<DOC>
	<DOCNO>NCT00245440</DOCNO>
	<brief_summary>The purpose study measure speed microbial eradication due azithromycin telithromycin acute maxillary sinusitis ( AMS ) .</brief_summary>
	<brief_title>Study Measure Impact Antibiotics Bacterial Flora Adults With Acute Sinusitis</brief_title>
	<detailed_description>The objective study : - To assess impact therapy telithromycin vs. azithromycin oral microflora patient acute maxillary sinusitis day 42 compare duration colonization resistant oropharyngeal flora patient treat azithromycin vs. telithromycin . - To also compare two treatment group rate reinfection within 6 week susceptibility pattern organism appear reinfection difference development resistance associate change symptom response .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Maxillary Sinusitis</mesh_term>
	<mesh_term>Telithromycin</mesh_term>
	<criteria>Adult patient , either male nonpregnant female , age 18 75 year age clinical finding acute maxillary sinusitis ( AMS ) , amenable serial sample nasopharynx oropharynx . Patients require specimen nasal nasopharyngeal drainage collect microbiological documentation within 24 hour prior enrollment . All patient must produce sinus fluid drainage . All patient produce nasal nasopharyngeal discharge sufficient baseline culture . Female patient child bear potential must agree use accepted method contraception ( i.e. , oral implant contraceptive barrier method , spermicide barrier method , intrauterine device [ IUD ] ) . The patient must agree continue method throughout study . Patients history recurrent sinusitis define three episode sinusitis require antibiotic therapy precede 12 month Patients history chronic sinusitis define symptom last great 28 day Patients nosocomial acquire sinusitis ( e.g. , hospitalization nonambulatory institutional confinement include nursing home within 2 week ) Patients need immediate surgery maxillary sinusitis previous sinus surgery within past 6 month sinus lavage within past 7 day Patients longterm ( &gt; 4 week ) user nasal decongestant ( e.g . oxymetazoline 0.05 % ) Patients know suspected hypersensitivity , know suspect serious adverse reaction , macrolide antibiotic Impaired hepatic renal function ( creatinine clearance [ CCL ] &lt; 20 ml/min ) Severe respiratory tract infection require hospitalization parenteral antibiotic therapy . Requirement concomitant antimicrobial agent topical , antiviral antifungal agent . Treatment macrolide , azalide , ketolide antimicrobial within 30 day prior entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>S.pneumonia</keyword>
	<keyword>sinusitis</keyword>
	<keyword>am</keyword>
	<keyword>azithromycin</keyword>
</DOC>